Insight journal, Insight journal - Company

Chugai Pharmaceutical: Partnering activity 2009-2014

Posted on 15 December 2014

Tags: , ,

Chugai Pharmaceutical, headquartered in Japan, is a subsidiary of Roche, having operations in Asia, Europe and North America. This company is now ranked as a Top 50 Pharma company by Current Partnering.

Since 2009, Chugai has entered into a number of partnering deals in the areas of cancer, psychiatry, immunology, infectious diseases and metabolic diseases.

The partnering activity of this ambitious company is reviewed in this article.

The following figure shows the level of Chugai Pharmaceutical partnering deal announcements since 2009. Although you can observe peaks and dips in the partnering activity, the company continues to bolster its product strength by partnering with big companies for different technologies.

Figure 1: Chugai Pharmaceutical partnering deals 2009-2014

Figure 1: Chugai Pharmaceutical partnering deals 2009-2014

Figure 1: Chugai Pharmaceutical partnering deals 2009-2014

Source: Current Agreements, 2014

Analysis of the partnering deals shows a strong emphasis on partnerships in cancer, psychiatry, immunology, infectious diseases and metabolic therapy areas. The company’s mission to excel and emerge as the top pharmaceutical company allows it to strategically partner to fill its therapeutic pipeline products. The company partners for products like antibodies, proteomics, cancer vaccine and diagnostics technology.

The following table provides an overview of the partnering deals announced by Chugai Pharmaceutical based on therapy area disclosed. Our report provides more detailed insight into the precise therapeutic target of each deal. See: Partnering Agreements with Chugai Pharmaceutical 2009-2014

Figure 2: Chugai Pharmaceutical partnering deals by therapy area 2009-2014

Figure 2: Chugai Pharmaceutical partnering deals by therapy area 2009-2014

Figure 2: Chugai Pharmaceutical partnering deals by therapy area 2009-2014

Source: Current Agreements, 2014

Further analysis of these deals shows that Chugai Pharmaceutical has a preference for licensing, marketing and development deals. A recent strategic alliance was the licensing deal with Epivax to incorporate Epivax’s ISPRI immunogenicity screening and deimmunization technology into Chugai’s drug development toolbox- more deal details.

The following table provides an overview of the partnering deals announced by Chugai Pharmaceutical based on deal type disclosed.

Figure 3: Chugai Pharmaceutical partnering deals by deal type 2009-2014

Figure 3: Chugai Pharmaceutical partnering deals by deal type 2009-2014

Figure 3: Chugai Pharmaceutical partnering deals by deal type 2009-2014

Chugai Pharmaceutical partnering at Current Agreements

View all partnering deals for Chugai Pharmaceutical: 2014 | 2013 | 2012 | 2011 | 2010 | 2009

Full details on each deal can be found at Current Agreements (subscription required)

Or purchase report: Partnering Agreements with Chugai Pharmaceutical 2009-2014

More

Summary profile data for Chugai Pharmaceutical

Partnering interests for Chugai Pharmaceutical

No M&A activity for Chugai Pharmaceutical  

Available reports from Current Partnering

Report: Partnering Agreements with Chugai Pharmaceutical 2009-2014 

Report: Top 50 Big Pharma Partnering and M&A deal trends

Available resources for deal coverage for Chugai Pharmaceutical

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Chugai Pharmaceutical company profile, recent partnering, M&A and financing news and articles

Related

Report: Finding Biopharma Licensing and Collaboration Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply